series-a
Stage
2016
Founded
2
Investors
About
TolerogenixX develops personalized cellular therapies to achieve immune tolerance in organ transplantation and autoimmune diseases, aiming to reduce reliance on long-term immunosuppressive drugs.
Explore TolerogenixX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.